Department of Ophthalmology and Visual Sciences, Michigan Medicine, Kellogg Eye Center, University of Michigan, Ann Arbor, MI, 48105, USA.
Esperovax Inc., Plymouth, MI, 48170, USA.
J Neuroinflammation. 2021 Aug 26;18(1):186. doi: 10.1186/s12974-021-02237-5.
Several retinal pathologies exhibit both inflammation and breakdown of the inner blood-retinal barrier (iBRB) resulting in vascular permeability, suggesting that treatments that trigger resolution of inflammation may also promote iBRB restoration.
Using the mouse retinal ischemia-reperfusion (IR) injury model, we followed the time course of neurodegeneration, inflammation, and iBRB disruption and repair to examine the relationship between resolution of inflammation and iBRB restoration and to determine if minocycline, a tetracycline derivative shown to reverse microglial activation, can hasten these processes.
A 90-min ischemic insult followed by reperfusion in the retina induced cell apoptosis and inner retina thinning that progressed for approximately 2 weeks. IR increased vascular permeability within hours, which resolved between 3 and 4 weeks after injury. Increased vascular permeability coincided with alteration and loss of endothelial cell tight junction (TJ) protein content and disorganization of TJ protein complexes. Shunting of blood flow away from leaky vessels and dropout of leaky capillaries were eliminated as possible mechanisms for restoring the iBRB. Repletion of TJ protein contents occurred within 2 days after injury, long before restoration of the iBRB. In contrast, the eventual re-organization of TJ complexes at the cell border coincided with restoration of the barrier. A robust inflammatory response was evident a 1 day after IR and progressed to resolution over the 4-week time course. The inflammatory response included a rapid and transient infiltration of granulocytes and Ly6C classical inflammatory monocytes, a slow accumulation of Ly6C monocyte/macrophages, and activation, proliferation, and mobilization of resident microglia. Extravasation of the majority of CD45 leukocytes occurred from the superficial plexus. The presence of monocyte/macrophages and increased numbers of microglia were sustained until the iBRB was eventually restored. Intervention with minocycline to reverse microglial activation at 1 week after injury promoted early restoration of the iBRB coinciding with decreased expression of mRNAs for the microglial M1 markers TNF-α, IL-1β, and Ptgs2 (Cox-2) and increased expression of secreted serine protease inhibitor Serpina3n mRNA.
These results suggest that iBRB restoration occurs as TJ complexes are reorganized and that resolution of inflammation and restoration of the iBRB following retinal IR injury are functionally linked.
几种视网膜病变既表现出炎症,又表现出内血视网膜屏障 (iBRB) 的破坏,导致血管通透性增加,这表明触发炎症消退的治疗方法也可能促进 iBRB 的恢复。
我们使用小鼠视网膜缺血再灌注 (IR) 损伤模型,跟踪神经退行性变、炎症和 iBRB 破坏和修复的时间过程,以检查炎症消退与 iBRB 恢复之间的关系,并确定米诺环素(一种已被证明可逆转小胶质细胞活化的四环素衍生物)是否可以加速这些过程。
视网膜 90 分钟缺血损伤后再灌注导致细胞凋亡和内视网膜变薄,这一过程持续了大约 2 周。IR 在数小时内增加了血管通透性,在损伤后 3 至 4 周内得到解决。血管通透性的增加与内皮细胞紧密连接 (TJ) 蛋白含量的改变和丢失以及 TJ 蛋白复合物的紊乱同时发生。从渗漏血管分流和渗漏毛细血管脱落被排除作为恢复 iBRB 的可能机制。TJ 蛋白含量在损伤后 2 天内恢复,远早于 iBRB 的恢复。相比之下,TJ 复合物在细胞边界的最终再组织与屏障的恢复同时发生。IR 后 1 天即可观察到强烈的炎症反应,并在 4 周的时间过程中进展至消退。炎症反应包括粒细胞和 Ly6C 经典炎症单核细胞的快速和短暂浸润、Ly6C 单核细胞/巨噬细胞的缓慢积累以及驻留小胶质细胞的激活、增殖和动员。大多数 CD45 白细胞的渗出发生在外丛状层。单核细胞/巨噬细胞的存在和小胶质细胞数量的增加一直持续到 iBRB 最终恢复。米诺环素干预以逆转损伤后 1 周的小胶质细胞活化促进了 iBRB 的早期恢复,同时伴有 TNF-α、IL-1β 和 Ptgs2(Cox-2)的小胶质细胞 M1 标志物的 mRNA 表达降低,以及分泌丝氨酸蛋白酶抑制剂 Serpina3n mRNA 的表达增加。
这些结果表明,iBRB 的恢复发生在 TJ 复合物被重新组织的过程中,并且视网膜 IR 损伤后炎症的消退和 iBRB 的恢复在功能上是相关的。